FONAR CORP (FONR) Stock Fundamental Analysis
USA - NASDAQ:FONR - US3444374058 - Common Stock
15.51 USD
+0.11 (+0.71%)
FONR gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 191 industry peers in the Health Care Equipment & Supplies industry. FONR is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. FONR has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year FONR was profitable.
In the past year FONR had a positive cash flow from operations.
In the past 5 years FONR has always been profitable.
In the past 5 years FONR always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of FONR (3.68%) is better than 79.58% of its industry peers.
FONR has a better Return On Equity (4.60%) than 76.96% of its industry peers.
FONR has a better Return On Invested Capital (4.51%) than 75.39% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for FONR is in line with the industry average of 8.46%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.68% | ||
| ROE | 4.6% | ||
| ROIC | 4.51% |
ROA(3y)4.96%
ROA(5y)4.84%
ROE(3y)6.44%
ROE(5y)6.47%
ROIC(3y)7.14%
ROIC(5y)7.07%
1.3 Margins
FONR has a better Profit Margin (7.67%) than 79.58% of its industry peers.
FONR's Profit Margin has declined in the last couple of years.
The Operating Margin of FONR (11.68%) is better than 78.01% of its industry peers.
In the last couple of years the Operating Margin of FONR has declined.
Looking at the Gross Margin, with a value of 41.23%, FONR is doing worse than 65.97% of the companies in the same industry.
In the last couple of years the Gross Margin of FONR has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.68% | ||
| PM (TTM) | 7.67% | ||
| GM | 41.23% |
OM growth 3Y-5.46%
OM growth 5Y-8.71%
PM growth 3Y-3.38%
PM growth 5Y-10.22%
GM growth 3Y-3.21%
GM growth 5Y-2.4%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so FONR is destroying value.
Compared to 1 year ago, FONR has less shares outstanding
Compared to 5 years ago, FONR has about the same amount of shares outstanding.
Compared to 1 year ago, FONR has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.70 indicates that FONR is not a great score, but indicates only limited risk for bankruptcy at the moment.
FONR has a better Altman-Z score (2.70) than 67.54% of its industry peers.
The Debt to FCF ratio of FONR is 0.06, which is an excellent value as it means it would take FONR, only 0.06 years of fcf income to pay off all of its debts.
FONR has a better Debt to FCF ratio (0.06) than 94.76% of its industry peers.
FONR has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
FONR's Debt to Equity ratio of 0.00 is fine compared to the rest of the industry. FONR outperforms 72.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.06 | ||
| Altman-Z | 2.7 |
ROIC/WACC0.52
WACC8.68%
2.3 Liquidity
FONR has a Current Ratio of 10.05. This indicates that FONR is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 10.05, FONR belongs to the best of the industry, outperforming 93.19% of the companies in the same industry.
FONR has a Quick Ratio of 9.86. This indicates that FONR is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of FONR (9.86) is better than 93.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 10.05 | ||
| Quick Ratio | 9.86 |
3. Growth
3.1 Past
FONR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -21.19%.
Measured over the past years, FONR shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.12% on average per year.
Looking at the last year, FONR shows a small growth in Revenue. The Revenue has grown by 0.29% in the last year.
Measured over the past years, FONR shows a small growth in Revenue. The Revenue has been growing by 3.36% on average per year.
EPS 1Y (TTM)-21.19%
EPS 3Y1.78%
EPS 5Y-7.12%
EPS Q2Q%37.05%
Revenue 1Y (TTM)0.29%
Revenue growth 3Y4.6%
Revenue growth 5Y3.36%
Sales Q2Q%5.63%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 13.26, the valuation of FONR can be described as correct.
FONR's Price/Earnings ratio is rather cheap when compared to the industry. FONR is cheaper than 89.01% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.41. FONR is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.26 | ||
| Fwd PE | N/A |
4.2 Price Multiples
FONR's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. FONR is cheaper than 98.95% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, FONR is valued cheaper than 95.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.2 | ||
| EV/EBITDA | 2.5 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for FONR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:FONR (9/18/2025, 8:00:00 PM)
15.51
+0.11 (+0.71%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners48.71%
Inst Owner Change-3.74%
Ins Owners5.07%
Ins Owner Change0%
Market Cap98.18M
Analysts0
Price TargetN/A
Short Float %0.99%
Short Ratio2.96
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.26 | ||
| Fwd PE | N/A | ||
| P/S | 0.95 | ||
| P/FCF | 12.2 | ||
| P/OCF | 8.43 | ||
| P/B | 0.57 | ||
| P/tB | 0.6 | ||
| EV/EBITDA | 2.5 |
EPS(TTM)1.17
EY7.54%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.27
FCFY8.2%
OCF(TTM)1.84
OCFY11.86%
SpS16.27
BVpS27.15
TBVpS25.97
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.68% | ||
| ROE | 4.6% | ||
| ROCE | 5.99% | ||
| ROIC | 4.51% | ||
| ROICexc | 6.18% | ||
| ROICexgc | 6.51% | ||
| OM | 11.68% | ||
| PM (TTM) | 7.67% | ||
| GM | 41.23% | ||
| FCFM | 7.81% |
ROA(3y)4.96%
ROA(5y)4.84%
ROE(3y)6.44%
ROE(5y)6.47%
ROIC(3y)7.14%
ROIC(5y)7.07%
ROICexc(3y)9.85%
ROICexc(5y)9.62%
ROICexgc(3y)10.45%
ROICexgc(5y)10.24%
ROCE(3y)9.49%
ROCE(5y)9.41%
ROICexcg growth 3Y-5.28%
ROICexcg growth 5Y-14.37%
ROICexc growth 3Y-4.76%
ROICexc growth 5Y-13.51%
OM growth 3Y-5.46%
OM growth 5Y-8.71%
PM growth 3Y-3.38%
PM growth 5Y-10.22%
GM growth 3Y-3.21%
GM growth 5Y-2.4%
F-Score6
Asset Turnover0.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.06 | ||
| Debt/EBITDA | 0.01 | ||
| Cap/Depr | 64.01% | ||
| Cap/Sales | 3.49% | ||
| Interest Coverage | 388.27 | ||
| Cash Conversion | 65.96% | ||
| Profit Quality | 101.82% | ||
| Current Ratio | 10.05 | ||
| Quick Ratio | 9.86 | ||
| Altman-Z | 2.7 |
F-Score6
WACC8.68%
ROIC/WACC0.52
Cap/Depr(3y)68.94%
Cap/Depr(5y)98.58%
Cap/Sales(3y)3.32%
Cap/Sales(5y)4.6%
Profit Quality(3y)113.41%
Profit Quality(5y)133.25%
High Growth Momentum
Growth
EPS 1Y (TTM)-21.19%
EPS 3Y1.78%
EPS 5Y-7.12%
EPS Q2Q%37.05%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.29%
Revenue growth 3Y4.6%
Revenue growth 5Y3.36%
Sales Q2Q%5.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-31.92%
EBIT growth 3Y-1.11%
EBIT growth 5Y-5.64%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-26.36%
FCF growth 3Y-4.82%
FCF growth 5Y-3.64%
OCF growth 1Y-24.06%
OCF growth 3Y-9.62%
OCF growth 5Y-6.24%